Dermatology · Baltimore area, MD
Dermatology and skin studies in Baltimore area, MD
7 recruiting studies have a site in the Baltimore area. This page includes nearby cities such as Towson, Columbia, Glen Burnie, Ellicott City.
7 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Pfizer
- Location
- Baltimore, MD + 28 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Sanofi
- Location
- Baltimore, MD + 17 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Incyte Corporation
- Location
- Baltimore, MD + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Incyte Corporation
- Location
- Baltimore, MD + 23 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU…
Celldex Therapeutics
- Location
- Baltimore, MD + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
AbbVie
- Location
- Baltimore, MD + 9 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 2
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
LISCure Biosciences
- Location
- Baltimore, MD + 3 other US sites
- Eligibility basics
- Ages 18–75
Who these studies look for
Most require an active, diagnosed skin condition of a certain severity and a pause on some current treatments before starting.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.